• COMPLETE HRIG CARE for all ages and sizes, including children1
  • COMPLETE HRIG COVERAGE with adequate volume to treat all wound types and animal exposures1,2
  • COMPLETE HRIG CONFIDENCE for all healthcare professionals helping to prevent rabies infections

Immediate Rabies Protection After Administration

KEDRAB is a human rabies immune globulin (HRIG) indicated for passive, transient post-exposure prophylaxis (PEP) of rabies infection to persons of all ages when given immediately after contact with a rabid or possibly rabid animal. KEDRAB should be administered concurrently with a full course of rabies vaccine.1
  • Ready-to-use HRIG: Sterile, aqueous solution for wound infiltration and intramuscular injection1
  • Dependable protection: Established real-world potency at 150 IU/mL3
  • Preservative-, latex-, and pyrogen-free1

No need to dilute with dextrose1

KEDRAB is designed, dosed, and packaged in accordance with American Society of Hospital Pharmacists (ASHP) guidelines on preventing medication errors.1,4

KEDRAB Works Immediately After Infiltration to Stop the Rabies Virus From Spreading1

*Please see the full Prescribing Information for additional information on patients not previously vaccinated, administering HRIG up to and including seven days after the first dose of rabies vaccine, previously vaccinated patients and any patients with a history of increased risk of hypersensitivity.

References: 1. KEDRAB [package insert]. Fort Lee, NJ: Kedrion Biopharma Inc.; 2020. 2. Bookstaver PB, Akpunonu P, Nguyen HB, Swan JT, Howington GT. Administration of rabies immunoglobulin: Improving evidence-based guidance for wound infiltration. Pharmacotherapy. 2021;41(8):644-648. 3. World Health Organization. WHO Expert Consultation on Rabies, third report. Geneva: World Health Organization; 2018 (WHO Technical Report Series, No. 1012). Licence: CC BY-NC-SA 3.0 IGO. 4. Billstein-Leber M, Carrillo CJD, Cassano AT, Moline K, Robertson JJ. ASHP Guidelines on Preventing Medication Errors in Hospitals. Am J Health Syst Pharm. 2018;75:1493-1517. doi: 10.2146/ajhp170811.


  • Enhanced color packaging for clear identification of 2mL and 10mL dosage options
  • User-friendly vertical barcodes on vials for easier scanning

New KEDRAB packaging, with distinctive vial sizes and colors, designed to reduce chances of error

Over the next several months, you can expect to start receiving KEDRAB® (Rabies Immune Globulin [Human]) with enhanced product packaging, as pictured above. Products with new packaging will be shipped when available, and after distributors' current supplies become depleted. As such, it is likely you may not receive both the new 2mL and 10mL product packaging at the same time.